01941nas a2200313   4500000000100000008004100001260001300042653002500055653001000080653002500090653003000115653001100145653001100156653001000167653000900177653001400186653001500200653001300215100001500228700001200243700001100255700001200266700001500278245007500293300001000368490000700378520122800385022001401613       2002                            d  c2002 Nov10aAdjustment Disorders10aAdult10aCase-Control Studies10aCross-Cultural Comparison10aFemale10aHumans10aIndia10aMale10aMorbidity10aPrevalence10aVitiligo1 aMattoo S K1 aHanda S1 aKaur I1 aGupta N1 aMalhotra R00aPsychiatric morbidity in vitiligo: prevalence and correlates in India.  a573-80 v163 a<p><b>BACKGROUND: </b>Vitiligo, a common pigmentary disorder, is recognized to be associated with a high psychiatric morbidity, yet compared to other dermatological disorders like leprosy, psoriasis, etc., it has not been subjected to detailed evaluation of its psychological consequences. The data from the developing countries on this aspect in particular is meager.</p><p><b>METHODS: </b>One hundred and thirteen cases with vitiligo were evaluated along with 55 healthy controls comparable for sociodemographic profile and matched on attitude to appearance scale. Clinical details, impact of illness, associated dysfunction and psychological morbidity were additionally assessed.</p><p><b>RESULTS: </b>Twenty-eight patients with vitiligo were found to have psychiatric morbidity, a clinic prevalence rate of 25% (95% confidence interval 20.3-29.3%). The majority of the cases had a diagnosis of adjustment disorder. Psychiatric morbidity was significantly correlated with dysfunction arising out of illness.</p><p><b>CONCLUSIONS: </b>Vitiligo is associated with high psychiatric morbidity. There is a need to develop cross-cultural database on psychosocial aspects and psychiatric morbidity associated with vitiligo.</p>  a0926-9959